Skip to main content

Month: July 2024

POET Technologies Announces US$10 Million Registered Direct Offering

TORONTO, July 19, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Corporation“) (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, is pleased to announce that it has completed a registered direct offering with a single institutional investor pursuant to which the Corporation issued 3,333,334 common shares (the “Common Shares“) and warrants exercisable to acquire 3,333,334 Common Shares (the “Warrants“) for aggregate gross proceeds of US$10,000,002 (the “Offering”). The combined price of one Common Share and accompanying Warrant in respect of one Common Share was US$3.00 (or approximately C$4.09)....

Continue reading

Alaska Energy Metals Announces Results of Its Annual General Meeting of Shareholders

VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) — Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF) (“Alaska Energy Metals” or the “Company”) today announced that all matters set out in the Management Information Circular dated April 26, 2024, as altered and supplemented by the addendum dated June 14, 2024 (the “Addendum”), for the 2024 Annual General Meeting of Shareholders originally scheduled and opened on June 10, 2024 and adjourned until July 18, 2024 were approved by the shareholders. Shareholders elected the six management nominees listed in the table below. The detailed results of the vote for the election of directors are set out below:MOTIONS NUMBER OF SHARES PERCENTAGE OF VOTES CASTFOR AGAINST WITHHELD/ABSTAIN SPOILED NON VOTE FOR AGAINST WITHHELD/ABSTAINNumber of Directors 1,502,083 37,581 0 0 0 97.56 % 2.44 % 0.00 %Mark...

Continue reading

CISO GLOBAL ANNOUNCES SOLUTION TO MITIGATE IMPACT OF CROWDSTRIKE SECURITY EVENT 

Scottsdale, Ariz., July 19, 2024 (GLOBE NEWSWIRE) — CISO Global (NASDAQ: CISO), CISO Global, an industry leader in proprietary software, managed cybersecurity, and compliance, announces that it has successfully identified and implemented a comprehensive solution to address the recent security incident involving CrowdStrike and Microsoft. This incident, resulting from a faulty update to CrowdStrike’s Falcon Sensor V6.58, caused widespread disruptions by triggering a Blue Screen of Death (BSOD) on thousands of Windows machines globally. CISO Global’s solution was developed after the Incident Response team studied affected networks and offers a clear path to recovery for those affected. CISO is deploying this successfully to affected customers. The faulty update caused critical faults in the Falcon Sensor’s driver...

Continue reading

Monroe Capital Corporation Schedules Second Quarter 2024 Earnings Release and Conference Call

CHICAGO, July 19, 2024 (GLOBE NEWSWIRE) — Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its second quarter 2024 financial results on Wednesday, August 7, 2024, after the close of the financial markets. The Company will host a webcast and conference call to discuss these operating and financial results on Thursday, August 8, 2024 at 11:00 a.m. Eastern Time. The webcast will be hosted on a webcast link located in the Investor Relations section of our website at http://ir.monroebdc.com/events.cfm. To participate in the conference call, please dial (800) 715-9871 approximately 10 minutes prior to the call. Please reference conference ID # 7213559. For those unable to listen to the live broadcast, the webcast will be available for replay on the Company’s website approximately two hours...

Continue reading

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

       Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosis At three months post procedure, the study’s primary endpoint of reduced acute pelvic pain in the HIFU treatment arm compared to the Sham treatment arm was not met Significant improvements were observed across primary and secondary outcome measures (endometriosis and digestive symptoms) across the entire study population at three months The Phase 3 study continues as planned per protocol, with patients from the Sham treatment arm electing HIFU therapyLYON, France, July 19, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced interim results from its Phase 3 study evaluating robotic High-Intensity...

Continue reading

Remitly to Report Second Quarter Financial Results on Wednesday, July 31, 2024

SEATTLE, July 19, 2024 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report second quarter 2024 financial results after the market close on Wednesday, July 31, 2024. Management will host a conference call and live webcast to present the Company’s financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly Second Quarter 2024 Financial Results Conference Call and Webcast Information:When: Wednesday, July 31st, 2024Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Toll Free Dial-in: To access the call, please use the following link: Remitly 2Q 2024...

Continue reading

IntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process

MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OTC: IGXT), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announced today that the Phase 1 Non-Binding LOI Submission Deadline set for 5:00 p.m. (EDT) on July 15, 2024 in connection with the previously announced sale and investment solicitation process (“SISP”) has lapsed. As Phase 1 of the SISP did not result in alternative superior bids, IntelGenx and atai Life Sciences AG (“atai”) have now initiated the process to complete the purchase and sale transaction. The parties currently expect to obtain final approval from the Québec Superior Court (Commercial Division) and close the transaction prior to September 30, 2024. About IntelGenx IntelGenx is a leading drug delivery...

Continue reading

Main Street Financial Services Corp. Declares Quarterly Dividend

WOOSTER, Ohio, July 19, 2024 (GLOBE NEWSWIRE) — Main Street Financial Services Corp. (OTCQX:MSWV), (the “Company”), the holding company parent of Main Street Bank Corp. (the “Bank”), has declared a cash dividend of $0.14 per share of the Company’s common stock for the quarter ending June 30th, 2024; an increase of 40.0 percent compared to the $0.10 per share in the second quarter of 2024. The quarterly cash dividend will be paid on August 16, 2024, to stockholders of record as of August 2, 2024. MSWV President & CEO, James VanSickle stated, “Main Street Financial Services Corp. is dedicated to maximizing shareholder value. The increase in our cash dividend is proof of our commitment to shareholders. Also, we have recently graduated to the OTCQX Market which will improve the exposure of MSWV common stock.” About MSWV: Main...

Continue reading

CORRECTION – Acme United Reports 29% Increase in Net Income for Second Quarter of 2024

SHELTON, Conn., July 19, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Acme United Corporation (NYSE American: ACU), please note that in the “CONDENSED CONSOLIDATED STATEMENTS OF INCOME” table, the “Net sales” figure for “Three Months Ended June 30, 2023” should be “53,336”, not “55,336” as previously stated, due to a typographical error. No other numbers or calculations were affected. The net sales figure for the three months ended June 30, 2023, was correctly stated as $53.3 million in the opening paragraph of the original release. The corrected release follows: Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2024 were $55.4 million compared to $53.3 million in the second...

Continue reading

Value Line, Inc. Declares a Quarterly Cash Dividend of $0.30 Per Common Share

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) —  Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors declared on July 19, 2024 a quarterly cash dividend of $0.30 per common share, payable on August 12, 2024, to stockholders of record on July 29, 2024. The Company has 9,418,074 shares of common stock outstanding as of July 19, 2024. Value Line, Inc. is a leading New York based provider of investment research. The Value Line Investment Survey is one of the most widely used sources of independent equity investment research. Value Line also publishes a range of proprietary investment research in both print and digital formats including research in the areas of Mutual Funds, ETFs and Options. Value Line’s acclaimed research also enables the Company to provide specialized products such as Value Line Select, The Value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.